Advisory: Polycystic Ovary Syndrome in FTMs (1997)
This is one of several medical advisories issued by AEGIS after being vetted by our 30-member advisory board. It was released in August, 1997 and re-released in 2002 by Gender Education & Advocacy, Inc., the renamed AEGIS. It also appeared in August, 1997 in the premiere issue of AEGIS’ Transgender Treatment Bulletin, accompanied by an article on PCOS by Jamison Green.
Read More
Transgender Treatment Bulletin (1997-1998)
In 1997 and 1998 the nonprofit American Educational Gender Information Service published three issues of the Transgender Treatment Bulletin. The bulletin addressed a variety of health issues faced by transsexual and transgender people and was meant to be read by both helping professionals and transfolk. I was editor and I did the layout and some of the writing.
Read More
AEGIS Public Service Advertisements (1990s)
AEGIS designed a series of public service ads, which ran on the inside front covers of Chrysalis Quarterly, the house journal. We also distributed them as flyers. The ads addressed assorted health issues of transsexual and transgendered people, including silicone injections, overuse of hormones, and HIV/AIDS. Margaux Schaffer designed the first two ads.
Read More
Beware Philip Salem (1991)
AEGIS’ first advisory was about a pill-peddler named Philip Salem.
Read More
AEGIS Recommends Breast Self-Examination (1995)
AEGIS recommends that all MTF transsexual and transgendered persons who have experienced significant breast development from hormonal therapy and all FTM transsexual and transgendered persons who have not had mastectomy/chest reconstruction do a breast self-examination on a monthly basis.
Read More
AEGIS Advisory on Vaginoplasty (1996)
This is one of several medical advisories issued by AEGIS after being vetted by our 30-member advisory board.
Read More
AEGIS Medical Advisory: Blanket Criterion for RLT Before Hormones is Unethical (1992)
AEGIS periodically released medical advisories. This one addressed the then-common practice of therapists to require an (often extensive) period of real-life experience before initiation of hormonal therapy. Our advisory board felt this constituted unnecessary risk for transsexuals and set them up for failure.
Read More
AEGIS Position Statements: Mandatory RLT Before Hormonal Therapy (1992, 1998)
AEGIS periodically released position statements. These from 1992 and 1998 addressed the then-common practice of therapists to require an (often extensive) period of real-life experience before initiation of hormonal therapy. Our advisory board felt this constituted unnecessary risk for transsexuals and set them up for failure.
Read More